PLRX

Pliant Therapeutics, Inc.
NasdaqGSUSDEQUITY Healthcare DELAYED
Last price
1.16
▲ 0.03 (3.12%)
MARKET ·

Price

Open
1.12
Prev close
1.12
Day high
1.17
Day low
1.12
Volume
504.68K
Market cap
$71.52M
P/E (TTM)
52W range
1.02 – 1.95

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+7.94% +9.3%
1M
+6.94% +3.2%
3M
-6.10% -9.2%
6M
-6.85% -17.9%
YTD
-5.33% -17.6%
1Y
-19.23% -39.2%
3Y
-93.28% -167.5%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$71.52M
Enterprise value$-57.84M
Revenue (TTM)
Gross profit
EBITDA$-89.87M
Net income$-92.29M
EPS (TTM)$-1.50
Free cash flow$-42.51M
Total cash$158.10M
Total debt$28.74M
Book value / share$2.37
Shares outstanding61.92M
Float55.03M
Short % of float4.64%
Dividend yield
Beta (5Y)1.27

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-0.87
PEG ratio
Price / sales
Price / book0.49
EV / revenue
EV / EBITDA0.64
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-50.29%
Return on assets-23.27%
Debt / equity19.56
Current ratio9.90
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

Annual · as reported
Last 4 fiscal years
Line item2025202420232022
Total revenue$0$0$1.58M$9.69M
Cost of revenue$0$0$0$0
Gross profit$0$0$0$0
R&D
SG&A
Operating income
Pre-tax income
Tax provision$0$0$0$0
Net income-$149.34M-$210.30M-$161.34M-$123.32M
EBIT$0$0$0$0

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -0.34-0.36 -4.4%
Dec 2025 -0.38-0.35 +6.5%
Sep 2025 -0.52-0.43 +17.8%
Jun 2025 -0.68-0.71 -4.8%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.34 4 $0 0.0%
Next quarter -0.38 4 $0 0.0%
Current year -1.46 4 $0 0.0%
Next year -1.33 4 $3.00M 0.0%

Analyst targets & ownership

Account required
Mean target$2.50
High target$3.00
Low target$2.00
Implied upside116.45%
Analyst count2
ConsensusHOLD
Strong buy / Buy0 / 0
Hold4
Sell / Strong sell0 / 1
Held by insiders2.23%
Held by institutions79.24%
Institutions holding113
Free account required

Price targets, consensus spread, insider and institutional ownership.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
1.38M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jan 20, 26
COULIE BERNARD J
Chief Executive Officer
SELL 89.38K $114.40K Direct
Jan 20, 26
CUMMINGS KEITH LAMONT
Chief Financial Officer
SELL 24.00K $30.72K Direct
Jan 20, 26
CHEUNG LILY
Officer
SELL 7.53K $9.64K Direct
Jan 20, 26
KUO MINNIE
Chief Operating Officer
SELL 6.92K $8.85K Direct
Jan 23, 25
LEFEBVRE ERIC
Officer
STOCK 45.65K $0 Direct
Jan 23, 25
HULL JOHANNES P.
Officer
STOCK 40.15K $0 Direct
Jan 23, 25
COULIE BERNARD J
Chief Executive Officer
STOCK 162.50K $0 Direct
Jan 23, 25
CUMMINGS KEITH LAMONT
Chief Financial Officer
STOCK 56.65K $0 Direct
Jan 23, 25
OUIMETTE MICHAEL
General Counsel
STOCK 35.00K $0 Direct
Jan 23, 25
CHEUNG LILY
Officer
STOCK 25.88K $0 Direct
Jan 22, 25
OUIMETTE MICHAEL
General Counsel
SELL 23.50K $261.10K Direct
Jan 17, 25
COULIE BERNARD J
Chief Executive Officer
SELL 52.42K $587.15K Direct
Jan 17, 25
CUMMINGS KEITH LAMONT
Chief Financial Officer
SELL 20.15K $225.68K Direct
Jan 17, 25
CHEUNG LILY
Officer
SELL 3.74K $41.89K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

7 reporting
NameRelationShares heldLatest
CHEUNG LILY
Officer 44.85K Sale
COULIE BERNARD J
Chief Executive Officer 914.92K Sale
CUMMINGS KEITH LAMONT
Chief Financial Officer 297.21K Sale
HULL JOHANNES P.
Officer 283.50K Stock Award(Grant)
KUO MINNIE
Chief Operating Officer 37.81K Sale
LEFEBVRE ERIC
Officer 240.22K Stock Award(Grant)
OUIMETTE MICHAEL
General Counsel 105.54K Stock Award(Grant)

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
1.10
+5.14% from price
SMA 20
1.08
+7.32% from price
SMA 50
1.11
+4.04% from price
SMA 100
1.17
-1.52% from price
SMA 200
1.25
-7.67% from price
EMA 12
1.11
+4.36% from price
EMA 26
1.10
+5.20% from price
EMA 50
1.12
+3.59% from price
RSI (14)
59.9
Neutral
MACD (12,26,9)
0.01
Hist 0.01
ATR (14)
0.05
4.12% of price
Realised vol 30D
40.1%
Annualised
Bollinger upper
1.16
20, 2σ
Bollinger lower
1.00
20, 2σ
50 / 200 cross
Death
1.11 vs 1.25
Trend bias
Below 200
-7.67%

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.92
Less volatile than market
Correlation to SPY
0.22
Largely independent
Realised vol 30D
40.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-44.9%
Peak to trough
Max drawdown 5Y
-97.2%
Peak to trough
ATR 14
0.05
4.12% of price
Beta (reported)
1.27
5Y monthly, from filing

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
1.03
Put-heavy session
Put / call open interest
13.83
Positioning, not flow
Max pain
1.00
-13.4% from spot
ATM implied vol
259.4%
Nearest strike to spot
Skew (10% OTM)
-14.8%
Calls bid over puts
Call volume
40
Contracts, this expiry
Put volume
41
Contracts, this expiry
Heaviest call OI
1.00
104 contracts
Heaviest put OI
1.00
2.24K contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 1.16
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.